Non-hodgkin Lymphoma

Non-Hodgkin lymphoma (NHL) is a type of cancer that originates in the lymphatic system. It is a complex disease with many different subtypes, each characterized by specific cellular and genetic features. NHL can affect people of all ages, although it tends to occur more frequently in individuals over the age of 60. The lymphatic system is an essential component of the immune system, responsible for protecting the body against infections and other foreign substances. Lymphocytes are a type of white blood cell that plays a crucial role in the lymphatic system. In NHL patients, these lymphocytes grow and multiply abnormally, forming tumors in various parts of the body. Symptoms of NHL can vary widely, depending on the location and stage of the tumors. Common symptoms include swollen lymph nodes, fever, weight loss, night sweats, and fatigue. NHL can be diagnosed through a variety of tests, including blood tests, biopsies, and imaging studies. Treatment options for NHL depend on the subtype and stage of the disease, as well as the patient's age and overall health. In many cases, treatment involves a combination of chemotherapy, radiation therapy, and immunotherapy. Clinical trials of novel therapies, such as CAR T-cell therapy and targeted therapies, are also ongoing. Advances in understanding the biology of NHL have led to the development of increasingly sophisticated treatments that can improve outcomes for patients. Hematology and oncology researchers continue to investigate new approaches to diagnosis, treatment, and prevention of NHL, with the hope of ultimately eradicating this disease.